Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Received MenACWY Conjugate Vaccine

NCT00856297 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

389

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningococcal Meningitis

Interventions

BIOLOGICAL: MenACWY-CRM conjugate vaccine
BIOLOGICAL: Licensed comparator

Sponsor

Novartis Vaccines

Collaborators

[object Object]